Advertisement

49. Endocannabinoid System in Posttraumatic Stress Disorder (PTSD) Early After Traumatic Injury

      In the immediate aftermath of injury it is unclear who demonstrates risk for posttraumatic stress disorder (PTSD). Pre-clinical data suggests the endocannabinoid signaling system responds to stress and acts as a buffer after trauma. The purpose of the present study was: 1) evaluate the role of early circulating endocannabinoid (2-AG, AEA) functioning in 6-month PTSD, and 2) evaluate polymorphisms of the cannabinoid receptor type 1 (CB1) and fatty acid amide hydrolase (FAAH) genes to determine differential PTSD risk. Based on preclinical data, we hypothesized lower 2-AG and AEA acutely after injury would confer risk for PTSD.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect